1093/N fundamentals
An in-depth look to CSPC PHARMACEUTICAL GROUP LIMITED operating, investing, and financing activities
1093/N free cash flow for H2 23 is 5.03 B MXN. For 2023, 1093/N free cash flow was 6.8 B MXN and operating cash flow was 10.71 B MXN.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
TTM